Title: | Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial |
Authors : | Szarek, Michael; ...; Dilić, Mirza; ...; Ristić, Arsen D. ; ...; Miličić, Davor; ...; Simić, Dragan V. ; Ivanović, Nikola;
Davidović, Goran T. ; Tasić, Nebojša M.; Ašanin, Milika R. ; Stojić, Stevo; Apostolović, Svetlana R. ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Aranđelović, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V. ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1581);
|
Issue Date: | 2019 |
Publication: | Journal of the American College of Cardiology |
ISSN: | 0735-1097 e1558-3597 Journal of the American College of Cardiology |
Publisher: | Elsevier Biomedical, New York |
Type: | Article |
Collation: | vol. 73 br. 4 str. 387-396 |
DOI: | 10.1016/j.jacc.2018.10.039 |
WoS-ID: | 000456818200001 |
Scopus-ID: | 2-s2.0-85060287356 |
URI: | https://enauka.gov.rs/handle/123456789/821567 |
URL: | https://www.sciencedirect.com/science/article/pii/S0735109718389617?via%3Dihub |
Project: | Sanofi-Aventis Regeneron Pharmaceuticals, Inc. Fondation Assistance Publique-Hopitaux de Paris |
Metadata source: | (Preuzeto iz Nasi u WoS) |
M-category: | |